Answer to Question 1
A
Feedback:
A patient diagnosed with myxedema cannot metabolize and excrete drugs, so she is at an increased risk of developing nephrotoxicity. Pulmonary congestion, tachycardia, and apnea are not adverse effects related to myxedema or the administration of ibuprofen (Motrin).
Answer to Question 2
D
Feedback:
If a patient is taking fluoxetine (Prozac) and is being switched to isocarboxazid (Marplan), the fluoxetine should be discontinued at least 5 weeks before starting the MAO inhibitor. Waiting less time than this before starting the isocarboxazid (Marplan) will place the patient at risk for serotonin syndrome.